March 19, 2009 - aycan Medical Systems has released its new version of aycan X-Ray-Print, designed to significantly increase image quality for all types of medical imaging prints.

March 19, 2009 - SenoRx Inc. said today it is entering the China market, including marketing its EnCor vacuum-assisted breast biopsy product and its GelMark line of breast biopsy tissue markers through its distribution partner, Beijing Eastwide Medical Ltd. (BJEW).

March 19, 2009 - LUMEDX Corp. today introduced its new software to collect interventional radiology procedural information at the point of care, the Interventional Radiology (IR).

March 18, 2009 – ContextVision released the new version of GOPView XR2-T, which allows for fine adjustment of the image quality in digital X-ray images.

DR Systems' Unity RIS/PACS platform includes breast imaging, reporting and tracking functions, aiming to provide a complete solution for digital mammography.

March 18, 2009 - Cardiologists Edward Tadajweski, M.D., and Jeffrey L. Williams, M.D., MS, FACC, are the first in the U.S. to perform 3D imaging of complex cardiac anatomy using GE's Innova 3D imaging system.

March 18, 2009 - The success of Massachusetts hospitals and physicians to incorporate information technology (IT) into healthcare demonstrates the importance of incentives, according to two studies conducted by CSC and sponsored by Blue Cross Blue Shield of Massachusetts.

March 18, 2009 - Women who require additional diagnostic imaging after a questionable mammogram may be at risk for unnecessary biopsies when only MRI is offered, according to a new study presented this week at NCBC 2009.

March 18, 2009 – Bioptics Inc., which develops imaging technology for the detection and treatment of cancer, announced at the NCBC 2009 annual conference that the FDA has granted it 510(k) clearance to use the Core VISION, a specimen radiography system, to analyze Core Biopsy samples.

March 18, 2009 - Cryosurgery produces clinical outcomes similar to those from external beam radiation therapy in localized prostate cancer at three years, but may be more beneficial with longer follow-up, according to a study sponsored by the Alberta Cancer Board and the National Cancer Institute of Canada.

Subscribe to
© Copyright Wainscot Media. All Rights Reserved.
Subscribe Now